Plasmodium chabaudi chabaudi and p. falciparum: Inhibition of aminopeptidase anti parasite growth by bestatin and nitrobestatin

  • M. F. Nankya-Kitaka
  • , G. P. Curley
  • , C. S. Gavigan
  • , A. Bell
  • , J. P. Dalton

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

83 Citations (Scopus)

Abstract

The major leucine aminopeptidase of the rodent malarial parasite Plasmodium chabaudi chabaudi was partially purified using a combination of high-pressure liquid chromatography on a size-exclusion column and affinity chromatography using the aminopeptidase-specific inhibitor bestatin as the ligand. The purified enzyme showed simple Michaelis-Menten kinetics when the fluorogenic peptide analogue leucyl-7-amino-4-methyl-courmarin served as the substrate, and it was strongly inhibited by both bestatin (K(i) = 50.7 ± 21.0 nM) and nitrobestatin (K(i) = 2.51 ± 0.2 nM) in a competitive manner. These inhibitors were also potent blockers of the growth of P. c. chabaudi and the human parasite P. falciparum in culture, and nitrobestatin was again the more potent. Therefore, the leucine aminopeptidase represents an important target to which novel anti-malarial agents could be directed.

Original languageEnglish
Pages (from-to)552-558
Number of pages7
JournalParasitology Research
Volume84
Issue number7
DOIs
Publication statusPublished - 1998
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Plasmodium chabaudi chabaudi and p. falciparum: Inhibition of aminopeptidase anti parasite growth by bestatin and nitrobestatin'. Together they form a unique fingerprint.

Cite this